Roobol MJ - Search Results

1

Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform.

Beyer K, Straten V, Remmers S, MacLennan S, MacLennan S, Gandaglia G, Willemse PM, Herrera R, Omar MI, Russell B, Huber J, Kreuz M, Asiimwe A, Abbott T, Briganti A, Van Hemelrijck M, Roobol MJ, The Prias Consortium, The Erspc Rotterdam Study Group, The Pioneer Consortium. Beyer K, et al. Among authors: roobol mj. J Pers Med. 2022 May 5;12(5):751. doi: 10.3390/jpm12050751. J Pers Med. 2022. PMID: 35629173 Free PMC article.

2

Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.

Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. Loeb S, et al. Among authors: roobol mj. Eur Urol. 2015 Apr;67(4):619-26. doi: 10.1016/j.eururo.2014.10.010. Epub 2014 Oct 31. Eur Urol. 2015. PMID: 25457014 Free PMC article. Review.

3

The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date.

Bruinsma SM, Zhang L, Roobol MJ, Bangma CH, Steyerberg EW, Nieboer D, Van Hemelrijck M; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Bruinsma SM, et al. Among authors: roobol mj. BJU Int. 2018 May;121(5):737-744. doi: 10.1111/bju.14106. Epub 2018 Jan 18. BJU Int. 2018. PMID: 29247473 Free article.

4

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study.

Drost FH, Rannikko A, Valdagni R, Pickles T, Kakehi Y, Remmers S, van der Poel HG, Bangma CH, Roobol MJ; PRIAS study group. Drost FH, et al. Among authors: roobol mj. Transl Androl Urol. 2018 Feb;7(1):98-105. doi: 10.21037/tau.2017.12.28. Transl Androl Urol. 2018. PMID: 29594024 Free PMC article.

5

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.

Schoots IG, Osses DF, Drost FH, Verbeek JFM, Remmers S, van Leenders GJLH, Bangma CH, Roobol MJ. Schoots IG, et al. Among authors: roobol mj. Transl Androl Urol. 2018 Feb;7(1):132-144. doi: 10.21037/tau.2017.12.29. Transl Androl Urol. 2018. PMID: 29594027 Free PMC article.

6

Results of Prostate Cancer Screening in a Unique Cohort at 19yr of Follow-up.

Osses DF, Remmers S, Schröder FH, van der Kwast T, Roobol MJ. Osses DF, et al. Among authors: roobol mj. Eur Urol. 2019 Mar;75(3):374-377. doi: 10.1016/j.eururo.2018.10.053. Epub 2018 Nov 9. Eur Urol. 2019. PMID: 30420254

7

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.

Verbeek JFM, Nieboer D, Parker C, Kattan MW, Steyerberg EW, Roobol MJ. Verbeek JFM, et al. Among authors: roobol mj. J Pers Med. 2019 Apr 22;9(2):19. doi: 10.3390/jpm9020019. J Pers Med. 2019. PMID: 31013571 Free PMC article.

8

Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancer.

Remmers S, Verbeek JFM, Nieboer D, van der Kwast T, Roobol MJ. Remmers S, et al. Among authors: roobol mj. BJU Int. 2019 Oct;124(4):635-642. doi: 10.1111/bju.14790. Epub 2019 May 30. BJU Int. 2019. PMID: 31055875 Free PMC article.

9

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.

Gandaglia G, Albers P, Abrahamsson PA, Briganti A, Catto JWF, Chapple CR, Montorsi F, Mottet N, Roobol MJ, Sønksen J, Wirth M, van Poppel H. Gandaglia G, et al. Among authors: roobol mj. Eur Urol. 2019 Aug;76(2):142-150. doi: 10.1016/j.eururo.2019.04.033. Epub 2019 May 12. Eur Urol. 2019. PMID: 31092338

10

Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.

van Leenders GJLH, Kweldam CF, Hollemans E, Kümmerlin IP, Nieboer D, Verhoef EI, Remmers S, Incrocci L, Bangma CH, van der Kwast TH, Roobol MJ. van Leenders GJLH, et al. Among authors: roobol mj. Eur Urol. 2020 Feb;77(2):191-198. doi: 10.1016/j.eururo.2019.07.051. Epub 2019 Aug 19. Eur Urol. 2020. PMID: 31439369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

488 results

Search Page